Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium.

Saved in:
Bibliographic Details
Title: Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium.
Authors: Kanwal F; Department of Medicine and the Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.; Houston VA Health Services Research and Development Service Center of Excellence, Michael E. DeBakey VA Medical Center, Houston, Texas, USA., Feng Z; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoshida Y; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Chhatwal J; Center for Health Technology Assessment, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA., Wong VW; Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China., Ioannou GN; Division of Gastroenterology and Hepatology, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA., Nahon P; AP-HP, Hôpitaux Universitaires Paris Seine Saint-Denis, Liver Unit, Bobigny, France.; Department of Hepatology, Université Sorbonne Paris Nord, Bobigny, France.; Inserm, UMR-1138 'Functional Genomics of Solid Tumors,' Centre de recherche des Cordeliers, Université de Paris, Paris, France., Lotter W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ning J; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA., Taouli B; Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Marquez G; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA., Fu SW; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA., Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Source: Hepatology (Baltimore, Md.) [Hepatology] 2026 Apr 20. Date of Electronic Publication: 2026 Apr 20.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-3350
DOI:10.1097/HEP.0000000000001745